Exact Mass: 307.0208
Exact Mass Matches: 307.0208
Found 169 metabolites which its exact mass value is equals to given mass value 307.0208,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Narciclasine
Narciclasine is a member of phenanthridines. It has a role as a metabolite. Narciclasine is a natural product found in Lycoris sanguinea, Lycoris squamigera, and other organisms with data available. A natural product found in Narcissus pseudonarcissus. Narciclasine is a plant growth modulator. Narciclasine modulates the Rho/Rho kinase/LIM kinase/cofilin signaling pathway, greatly increasing GTPase RhoA activity as well as inducing actin stress fiber formation in a RhoA-dependent manner.
2'-Deoxycytidine-5'-monophosphoric acid
Deoxycytidine monophosphate (dCMP), also known as deoxycytidylic acid or deoxycytidylate in its conjugate acid and conjugate base forms, respectively, is a deoxynucleotide, and one of the four monomers that make up DNA. In a DNA double helix, it will base pair with deoxyguanosine monophosphate. dCMP belongs to the class of organic compounds known as pyrimidine 2-deoxyribonucleoside monophosphates. These are pyrimidine nucleotides with a monophosphate group linked to the ribose moiety lacking a hydroxyl group at position 2. Deficiency of the enzyme deoxycytidine kinase (EC2.7.1.74) is associated with resistance to antiviral and anticancer chemotherapeutic agents, whereas increased enzyme activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. dCMP exists in all living species, ranging from bacteria to humans. Within humans, dCMP participates in a number of enzymatic reactions. In particular, dCMP can be converted to dCDP by the enzyme UMP-CMP kinase 2. In addition, dCMP can be converted into deoxycytidine, which is catalyzed by the enzyme cytosolic purine 5-nucleotidase. In humans, dCMP is involved in the metabolic disorder called ump synthase deficiency (orotic aciduria). Outside of the human body, dCMP has been detected, but not quantified in several different foods, such as turnips, garlics, agaves, garden onions, and italian sweet red peppers. dCMP is a deoxycytosine nucleotide containing one phosphate group esterified to the deoxyribose moiety in the 2-,3- or 5- positions. Deoxycytidine (dihydrogen phosphate). A deoxycytosine nucleotide containing one phosphate group esterified to the deoxyribose moiety in the 2-,3- or 5- positions. 2'-Deoxycytidine-5'-monophosphoric acid is an endogenous metabolite. 2'-Deoxycytidine-5'-monophosphoric acid is an endogenous metabolite.
N-(6-Oxo-6H-dibenzo[b,d]pyran-3-yl)-2,2,2-trifluoroacetamide
6-(2,2,2-Trifluoroacetamide)-3,4-benzocoumarin
Quinoxyfen
CONFIDENCE standard compound; INTERNAL_ID 527; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10416; ORIGINAL_PRECURSOR_SCAN_NO 10415 CONFIDENCE standard compound; INTERNAL_ID 527; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10466; ORIGINAL_PRECURSOR_SCAN_NO 10465 CONFIDENCE standard compound; INTERNAL_ID 527; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10354; ORIGINAL_PRECURSOR_SCAN_NO 10353 CONFIDENCE standard compound; INTERNAL_ID 527; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10475; ORIGINAL_PRECURSOR_SCAN_NO 10473 CONFIDENCE standard compound; INTERNAL_ID 527; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10460; ORIGINAL_PRECURSOR_SCAN_NO 10458 CONFIDENCE standard compound; INTERNAL_ID 527; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10391; ORIGINAL_PRECURSOR_SCAN_NO 10389 CONFIDENCE standard compound; INTERNAL_ID 4055 CONFIDENCE standard compound; INTERNAL_ID 8431 CONFIDENCE standard compound; INTERNAL_ID 2547
Nitazoxanide
Nitazoxanide, also known by the brand name Alinia, is a synthetic nitrothiazolyl-salicylamide derivative and an anti-protozoal agent. It is approved for treatment of infectious diarrhea caused by Cryptosporidium parvum and Giardia lamblia in patients 1 year of age and older. Following oral administration it is rapidly hydrolyzed to its active metabolite, tizoxanide, which is 99\\% protein bound. Peak concentrations are observed 1-4 hours after administration. It is excreted in the urine, bile and feces. Untoward effects include abdominal pain, vomiting and diarrhea. [Wikipedia] P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-oxobrimonidine
2-oxobrimonidine is a metabolite of brimonidine. Brimonidine (bri-MOE-ni-deen, brand names Alphagan and Alphagan-P) is a drug used to treat open-angle glaucoma or ocular hypertension. It acts via decreasing synthesis of aqueous humor, and increasing the amount that drains from the eye through uveoscleral outflow. As a treatment for glaucoma, it is usually given in eyedrop form. (Wikipedia)
2'-deoxycytidine 3'-monophosphate
2-deoxycytidine 3-monophosphate is classified as a member of the Ribonucleoside 3-phosphates. Ribonucleoside 3-phosphates are ribonucleosides that contain a phosphate group attached to the C-3 carbon of the ribose or deoxyribose moiety. The nucleobases here are limited to purine, pyrimidine, and pyridine derivatives. 2-deoxycytidine 3-monophosphate is considered to be soluble (in water) and acidic
Clopidogrel carboxylic acid
D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
Laromustine
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent C471 - Enzyme Inhibitor > C2134 - O6-Alkylguanine-DNA Alkyltransferase Inhibitor
Narciclasine
Tafamidis
C87006 - Pharmacological Chaperone N - Nervous system
11-Hydroxy-5H-benzo[g]-1,3-benzodioxolo[6,5,4-de]quinoline-5,6(7H)-dione
clopidogrel carboxylic acid
A thienopyridine that is 6,7-dihydrothieno[3,2-c]pyridin-5(4H)-ylacetic acid substituted by a 2-chlorophenyl group at position 2. It is a metabolite of the drug clopidogrel. D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors CONFIDENCE standard compound; EAWAG_UCHEM_ID 2854
3-oxo-3-phenyl-1-(3-thienyl)propyl aminomethanedithioate
N-(6-chloro-1,3-benzothiazol-2-yl)-3,5-dimethyl-1,2-oxazole-4-carboxamide
1,2,3,7-tetrahydroxy-1,3,4,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-6-one|Narciclasin = 1,2,3,7-Tetrahydro-8,9-methylendihydroxy-1,2,3,7-tetrahydroxy-phenanthridon|narciclasine
4-(2-Amino-1H-imidazole-4-yl)-3-bromo-6,7-dihydropyrrolo[2,3-c]azepine-8(1H)-one
7-Butyl-2-chloro-6,8-dihydroxy-9H-pyrrolo[2,1-b][1,3]benzoxazine-9-one
2-Deoxycytidine 5-monophosphate
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.054 2'-Deoxycytidine-5'-monophosphoric acid is an endogenous metabolite. 2'-Deoxycytidine-5'-monophosphoric acid is an endogenous metabolite.
dCMP
2'-Deoxycytidine-5'-monophosphoric acid is an endogenous metabolite. 2'-Deoxycytidine-5'-monophosphoric acid is an endogenous metabolite.
NSC 697855
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-DEOXYCYTIDINE 5-MONOPHOSPHATE
2'-Deoxycytidine-5'-monophosphoric acid is an endogenous metabolite. 2'-Deoxycytidine-5'-monophosphoric acid is an endogenous metabolite.
Deoxycytidine monophosphate
2'-Deoxycytidine-5'-monophosphoric acid is an endogenous metabolite. 2'-Deoxycytidine-5'-monophosphoric acid is an endogenous metabolite.
tert-butyl N-(5-chloro-2-methylsulfonylpyrimidin-4-yl)carbamate
2-(4-CHLOROPHENYL)-6-MORPHOLIN-4-YL-THIOPYRAN-4-ONE
N-(5-BROMO-1,4-DIHYDRO-4-OXO-6-PHENYL-2-PYRIMIDINYL)-ACETAMIDE
Sulfanilamide, N1-(5-ethyl-1,3,4-thiadiazol-2-yl)-, monosodium salt
6-CHLOROQUINOLINE-2,3-DICARBOXYLIC ACID DIETHYL ESTER
2-tert-butyl-6-chloro-benzooxazole-7-sulfonyl chloride
6,8-DICHLORO-N-(PYRIDIN-4-YL)IMIDAZO[1,2-B]PYRIDAZINE-3-CARBOXAMIDE
6-CHLORO-3-(3-CHLORO-2-FLUOROBENZYLIDENE)INDOLIN-2-ONE
5-chloro-3-(4-chlorophenyl)sulfanyl-2-methyl-1H-indole
6-chloro-3-(4-chlorophenyl)sulfanyl-2-methyl-1H-indole
2-CHLORO-2-[2-(4-CHLOROPHENYL)HYDRAZONO]-N-PHENYLACETAMIDE
4-(5-BROMOPYRIMIDIN-2-YLAMINO)BENZOIC ACID METHYL ESTER
Methyl 2-amino-4-(3-bromophenyl)pyrimidine-5-carboxylate
1-(8-Bromo-3,4-dihydroisoquinolin-2(1H)-yl)-2,2,2-trifluoroethanone
2-(3,4-dichlorophenyl)-3-methyl-1,1-dioxo-1,3-thiazinan-4-one
2-chloro-N-(4-chlorophenyl)-3-oxo-3-phenylpropanamide
3-Chloro-6-methyl-dibenzo[c,f][1,2]thiazepin-11(6H)-one 5,5-Dioxide
2-Methoxyethyl 1- methylethyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate
DDAO
D013501 - Surface-Active Agents > D003902 - Detergents
N-(5-Chloropyridin-2-yl)-5-methoxy-2-nitrobenzamide
7-CHLOROQUINOLINE-2,3-DICARBOXYLIC ACID DIETHYL ESTER
2-(4-Phenyl-1,2,3-thiadiazol-5-yl)isoindoline-1,3-dione
4-HYDROXY-3-(4-METHYLPHENYLSULFONAMIDO)BENZOICACID
1-(6-bromo-3,4-dihydro-2(1H)-isoquinolinyl)-2,2,2-trifluoro-Ethanone
2-chloro-4-(5-fluoro-2-methylbenzamido)benzoic acid
7-BENZENESULFONYL-4-CHLORO-6-METHYL-7H-PYRROLO[2,3-D]PYRIMIDINE
5-azido-1,3,8-trimethyl-6-nitropyrido[2,3-d]pyrimidine-2,4,7-trione
4,5-DIMETHOXY-2-[(THIOPHENE-2-CARBONYL)-AMINO]-BENZOIC ACID
3-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile
N-(6-Bromonaphthalen-2-yl)-2-hydroxy-2-methylpropanamide
4-OXO-4-[1-(PHENYLSULFONYL)-1H-PYRROL-3-YL]BUTANOIC ACID
1H-Naphth[2,3-f]isoindole-1,3,5,10(2H)-tetrone,4,11-diamino-
8-CHLOROQUINOLINE-2,3-DICARBOXYLIC ACID DIETHYL ESTER
Ethanone, 1-(7-bromo-3,4-dihydro-2(1H)-isoquinolinyl)-2,2,2-trifluoro-
2-(4-METHOXYPHENOXY)-5-NITROBENZENE-1-CARBONYL CHLORIDE
4-BENZYLOXY-5-BROMO-2-(N,N-DIMETHYLAMINO)PYRIMIDINE
Thieno[3,2-d]pyrimidine, 2-chloro-4-(3-nitrophenoxy)-
(S)-ethyl 2-amino-3-(4-bromophenyl)propanoate hydrochloride
Histamine phosphate
V - Various > V04 - Diagnostic agents > V04C - Other diagnostic agents > V04CG - Tests for gastric secretion D018377 - Neurotransmitter Agents > D018494 - Histamine Agents C308 - Immunotherapeutic Agent > C2139 - Immunostimulant Histamine (phosphate) is a strong histamine receptor activator and vasodilator neuroagent, capable of activating nitric oxide synthase. Histamine (phosphate) is a strong histamine receptor activator and vasodilator neuroagent, capable of activating nitric oxide synthase. Histamine (phosphate) is a strong histamine receptor activator and vasodilator neuroagent, capable of activating nitric oxide synthase.
Methyl 2-amino-4-(4-bromophenyl)pyrimidine-5-carboxylate
3-bromo-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one
3-pyridin-2-yl-5-[3-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole
(7-BROMO-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)(4-NITROPHENYL)METHANONE
3-Bromo-7-cyclohexyl-2,5-dimethylpyrazolo[1,5-a]pyrimidine
3-Acetyl-6-bromo-2-methylquinoline-4-carboxylic acid
4-chloro-N-[[(4,6-dimethyl-2-pyrimidinyl)thio]methyl]benzamide
4-chloro-N-[5-(2,3-dihydro-1,4-dioxin-5-yl)-1,3,4-oxadiazol-2-yl]benzamide
2-(2,6-Dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid
Laromustine
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent C471 - Enzyme Inhibitor > C2134 - O6-Alkylguanine-DNA Alkyltransferase Inhibitor
4-chloro-N-[2-(4-chlorophenyl)-2-oxoethyl]benzamide
5-bromo-N-(4-propan-2-ylphenyl)-2-furancarboxamide
N-[[(4-fluorobenzoyl)amino]carbamothioyl]furan-2-carboxamide
1-(4-Methoxyphenyl)-3-[[oxo(thiophen-2-yl)methyl]amino]thiourea
3-(3-Bromoanilino)-1-(5-methyl-2-furanyl)-1-propanone
2-bromo-N-[2-(7-hydroxy-1-naphthalenyl)ethyl]acetamide
Sodium 6-(1-hydroxyethyl)-7-oxo-3-(oxolan-2-YL)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
Deoxycytidine 5-monophosphate
A pyrimidine 2-deoxyribonucleoside 5-monophosphate having cytosine as the nucleobase. 2'-Deoxycytidine-5'-monophosphoric acid is an endogenous metabolite. 2'-Deoxycytidine-5'-monophosphoric acid is an endogenous metabolite.
[5-(4-Amino-2-oxohydropyrimidinyl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phos phate
bisphenol A sulfate(1-)
A phenyl sulfate oxoanion that is the conjugate base of bisphenol A sulfate, obtained by deprotonation of the sulfo group; major species at pH 7.3.
